Prediction of Susceptibility to First-Line Tuberculosis Drugs by DNA Sequencing. (2018)
Attributed to:
Comprehensive Resistance Prediction for Tuberculosis: an International Consortium (CRyPTIC)
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1056/nejmoa1800474
PubMed Identifier: 30280646
Publication URI: http://europepmc.org/abstract/MED/30280646
Type: Journal Article/Review
Volume: 379
Parent Publication: The New England journal of medicine
Issue: 15
ISSN: 0028-4793